8 assets in Retinoblastoma

Therapeutic assets addressing Retinoblastoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Retinoblastoma	Seattle Children's Hospital	P2	BB (66)
Palbociclib Retinoblastoma	Brown University	P1	CC (43)
Pembrolizumab Retinoblastoma	Seattle Children's Hospital	P1	CC (43)
Pimitespib Retinoblastoma	Brown University	P1	CC (43)
Second Generation 4-1Bbζ B7H3-Egfrt-Dhfr Retinoblastoma	Seattle Children's Hospital	P1	CC (43)
Second Generation 4-1Bbζ Egfr806-Egfrt Retinoblastoma	Seattle Children's Hospital	P1	CC (43)
Second Generation 4-1Bbζ Egfr806-Egfrt And A Second Generation 4 1Bbζ Cd19-Her2Tg Retinoblastoma	Seattle Children's Hospital	P1	CC (43)
Cid-078 Monotherapy Retinoblastoma	Circle Pharma	P1	NR ()